RIPK3 and malignant colon neoplasm: Nugues et al. have identified a significant reduction in RIPK3 expression in acute myeloid leukemia samples [40], while in colon cancer tissues both RIPK1 and RIPK3 appeared to be downregulated versus adjacent normal tissue [41].